Ca2+ signaling down-regulation in ageing and Alzheimer's disease: Why is Ca2+ so difficult to measure?

Cell Calcium

Volumn 26, Issue 3-4, 1999, Pages 149-154

  Chen, M ^a   Fernandez, H L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CALCIUM CELL LEVEL; COGNITION; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CALCIUM SIGNALING; DOWN REGULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; CALCIUM; CALCIUM SIGNALING; DOWN-REGULATION; HUMANS;

EID: 0032585967     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1054/ceca.1999.0067     Document Type: Article

References (36)

1. Thibault O., Porter N. M., Chen K-C. Calcium dysregulation in neuronal ageing and Alzheimer's disease: history and new directions. Cell Calcium. 24:1998;417-433.
2. Verkhratsky A., Toescu E. C. Calcium and neuronal ageing. Trends Neurosci. 21:1998;2-7.
3. Berridge M. J., Bootman M. D., Lipp P. Calcium - a life and death signal. Nature. 395:1998;645-648.
4. Kandel E. R., Schwartz J. H. Principles of Neural Science. 3rd edn. 1991;New York, Simon & Schuester
5. Khachaturian Z. S. Calcium hypothesis of Alzheimer's disease and brain ageing. Ann NY Acad Sci. 747:1994;1-11.
6. Disterhoft J. F., Gispen W. E., Traber J., Khachaturian Z. S. (eds). Calcium hypothesis of ageing and dementia. Ann NY Acad Sci. 1994;747.
7. Müller W. E., Gispen W. (eds). Current status of the calcium hypothesis of brain ageing and Alzheimer's disease. Life Sci. 1996;59.
8. Katz B., Miledi R. The timing of calcium action during neuromuscular transmission. J Physiol. 189:1967;535-544.
9. Miller R. J. Calcium signaling in neurons. Trends Neurosci. 11:1988;415-419.
10. Albert B., Bray D., Lewis J., Raff M., Roberts K., Watson J. D. Molecular Biology of the Cell 2rd edn. 1989;Garland, New, York
11. Gibson G. E., Peterson C. Calcium and the ageing nervous system. Neurobiol Ageing. 8:1989;329-343.
12. Khachaturian Z. S. Hypothesis on the regulation of cytosol calcium concentration and the ageing brain. Neurobiol Ageing. 8:1989;345-346.
13. Nixon R. A. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann NY Acad Sci. 568:1989;198-208.
14. Disterhoft J. F., Moyer J. R., Thompson L. T. The calcium rationale in ageing and Alzheimer's disease. Ann NY Acad Sci. 747:1994;382-406.
15. Chen M. Alzheimer's α-secretase may be a calcium-dependent protease. FEBS Lett. 417:1997;163-167.
16. Chen M. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part I: a calcium deficit hypothesis. Front Biosci. 3:1998;a27-31.
17. Chen M. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part II: therapeutic rationale. Front Biosci. 3:1998;a32-37.
18. Chen M. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part III: animal model. Front Biosci. 3:1998;a47-51.
19. Chen M., Fernandez H. L. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part IV: can calpain act as α-secretase in vivo? Front Biosci. 3:1998;a66-75.
20. Chen M., Fernandez H. L. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease? Front Biosci. 4:1999;a9-15.
21. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical nerusons vulnerable to excitotoxicity. J Neurosci. 12:1992;376-389.
22. Lust W. D. Problems in assessing altered calcium homeostasis in the ageing nervous system. Neurobiol Ageing. 8:1987;353-354.
23. Perterson C. Changes in calcium's role as a messenger during ageing in neuronal and non-neuronal cells. Ann NY Acad Sci. 663:1992;279-293.
24. Cassel C. K., Cohen H. J., Larson EB (eds). Geriatric Medicine, 3rd edn. 1997;New York, Springer
25. Hyman B. T., Van Hoesen G. W., Damasio A. R. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol. 22:1987;37-40.
26. Hattori N., Kitagawa K., Higashida T., Yagyu K., Shimohama S., Wataya T., Perry G., Smith M. A., Inagaki C. Cl-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains. Neurosci Lett. 254:1998;141-144.
27. De Koninck P., Schulman H. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science. 279:1998;227-230.
28. Putney J. W. Jr. Calcium signaling: up, downs, up, down ... what's the point? Science. 279:1998;191-192.
29. Saito K-I., Elce J. S., Hamos J. E., Nixon R. A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA. 90:1993;2628-2632.
30. Lynch G., Baudry M. Brain spectrin, calpain and long-term changes in synaptic efficacy. Brain Res Bull. 18:1987;809-815.
31. Schmage N., Bergener M. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Intl Psychogeriatrics. 1 (suppl 4):1992;89-99.
32. Heckbert S. R., Longstreth W. T. Jr, Psaty B. M. The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults. J Am Geriatr Soc. 45:1997;1423-1433.
33. Mattson M. P., Rydel R. E., Lieberburg I., Smith-Swintosky V. L. Altered Calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples. Ann NY Acad Sci. 679:1993;1-21.
34. Taylor R. A lot of 'excitement' about neurodegeneration. Science. 252:1991;1380-1381.
35. Lee J-M., Zipfel G. J., Choi D. W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399(suppl):1999;A7-14.
36. Tang Y. P., Shimizu E., Dube G. R. Genetic enhancement of learning and memory in mice. Nature. 401:1999;63-69.